Search

Displaying results 7031 - 7040 of 10000 in total
  1. Drug

    PARPI F-18

    go.drugbank.com/drugs/DB18657
    Experimental

    PARPI F-18 is a diagnostic agent under investigation for use in the management of glioblastoma multiforme.

  2. Drug

    Ivonescimab

    go.drugbank.com/drugs/DB18931
    Investigational

    Ivonescimab is under investigation in clinical trial NCT05184712 (Phase 3 Clinical Study of AK112 for NSCLC Patients).

  3. Drug

    Lactide, L-

    go.drugbank.com/drugs/DB19115
    Investigational

    Lactide, L- is under investigation in clinical trial NCT05450471 (Effectiveness of Endonasal Polymeric Implant for Chronic Rhinosinusitis).

  4. Drug

    Asunercept

    go.drugbank.com/drugs/DB15160
    Investigational

    Asunercept is under investigation in clinical trial NCT02853565 (A Study of CAN008 for Newly Diagnosed Glioblastoma Multiforme).

  5. Drug

    NSI-189

    go.drugbank.com/drugs/DB16230
    Investigational

    NSI-189 is under investigation in clinical trial NCT02695472 (Study of NSI-189 for Major Depressive Disorder).

  6. Drug

    ONO-2952

    go.drugbank.com/drugs/DB14802
    Investigational

    ONO-2952 is under investigation in clinical trial NCT01887002 (Study to Evaluate the Effects of ONO-2952 on Pain Perception Produced by Rectal Distention in Female Subjects With Diarrhea-Predominant Irritable

  7. Drug

    Deuterium oxide

    go.drugbank.com/drugs/DB19251
    Investigational

    Categories: Compounds used in a research, industrial, or household setting
  8. Drug

    Lentinan

    go.drugbank.com/drugs/DB13480
    Investigational

    Categories: Compounds used in a research, industrial, or household setting
  9. Drug

    Guadecitabine

    go.drugbank.com/drugs/DB11918
    Investigational

    Guadecitabine is under investigation for the treatment of Previously Treated Metastatic Colorectal Cancer.

  10. Drug

    NGM707

    go.drugbank.com/drugs/DB28351
    Investigational

    NGM707 is a humanized IgG antibody with specificity for both LILRB1 and LILRB2.